Psychedelic Drug Development & Regulation | Rethinking Psychedelic Treatment for Mental Health
Psychedelic Drug Development & Regulation | Rethinking Psychedelic Treatment for Mental Health
Like0000000or copy the linkDr. Tiffany Farchione (Director – Psychiatry, Food & Drug Administration) in conversation with Brie Jackson (Deputy DC Bureau Chief, NewsNation) What If the Breakthrough Was Already Here: Rethinking Psychedelic Treatment for America’s [More]
493 views
no comments
New development on Beaumont convention center project
New development on Beaumont convention center project
Like0000000or copy the linkThe Beaumont City Council is considering a proposal to increase the hotel occupancy tax from 15% to 17% to fund a project for the downtown Beaumont Convention Center. The council approved an [More]
651 views
no comments
An Open Science approach to drug development – Prof. Dr. Charles Raison, MD
An Open Science approach to drug development – Prof. Dr. Charles Raison, MD
Like0000000or copy the linkAn Open Science approach to drug development Science advances more from collaboration than competition. In the burgeoning field of psychedelic research, we purport that openness, transparency, and collaboration will move this field [More]
658 views
no comments
The Psychedelic Therapeutics and Drug Development Conference
The Psychedelic Therapeutics and Drug Development Conference
Like0000000or copy the linkIn this panel, field expert’s Dr Malcolm Barratt-Johnson and Graeme McFarlane will discuss the work of Albert Labs in utilising psilocybin as a means of treating cancer related anxiety, as well as [More]
585 views
no comments